These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 2174294)
1. Efficacy of a killed gpX deleted pseudorabies virus vaccine. Cook DR; Hill HT; Kinker DR Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294 [TBL] [Abstract][Full Text] [Related]
2. Evaluation in swine of a subunit vaccine against pseudorabies. Maes RK; Schutz JC Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337 [TBL] [Abstract][Full Text] [Related]
3. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Qian P; Li XM; Jin ML; Peng GQ; Chen HC Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769 [TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659 [TBL] [Abstract][Full Text] [Related]
5. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Firkins LD; Weigel RM; Biehl LG; Hahn EC Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001 [TBL] [Abstract][Full Text] [Related]
6. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV. Kit S; Kit M; McConnell S; Lawhorn B Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426 [TBL] [Abstract][Full Text] [Related]
7. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure. Kelling CL; Staudinger WL; Rhodes MB Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139 [TBL] [Abstract][Full Text] [Related]
8. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs. Arellano PE; Morrison RB; Molitor TW; Thawley DG J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793 [TBL] [Abstract][Full Text] [Related]
9. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine. Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620 [TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
11. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. van Oirschot JT; Gielkens AL Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I. van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs. Mengeling WL; Brockmeier SL; Lager KM Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615 [TBL] [Abstract][Full Text] [Related]
14. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Kit S; Sheppard M; Ichimura H; Kit M Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972 [TBL] [Abstract][Full Text] [Related]
15. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs. Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244 [TBL] [Abstract][Full Text] [Related]
16. Antibody response of pigs to inactivated monovalent and bivalent vaccines for porcine parvovirus and pseudorabies virus. Mengeling WL; Gutekunst DE; Pirtle EC Am J Vet Res; 1980 Oct; 41(10):1569-71. PubMed ID: 6261613 [TBL] [Abstract][Full Text] [Related]
17. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus. Chen ZH; Guo X; Ge XN; Jia H; Yang HC Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306 [TBL] [Abstract][Full Text] [Related]
18. Genetic engineering of the pseudorabies virus genome to construct live vaccines. Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1. Mikulska-Skupień E; Szweda W; Procajło Z Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine. Swenson SL; McMillen J; Hill HT J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]